Home › Funds › P2 Capital Partners, LLC › ENOV
P2 Capital Partners, LLC position in ENOV
ENOVIS CORPORATION · Health Care
P2 Capital Partners, LLC reported holding 320,000 shares of ENOV (ENOVIS CORPORATION) in its Q3 2026 13F filing — a position valued at US$5.8M, representing 1.95% of its reported portfolio and ranking #14 among its reported holdings. P2 Capital Partners, LLC has disclosed ENOV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How P2 Capital Partners, LLC's ENOV position evolved
P2 Capital Partners, LLC first disclosed a stake in ENOV in Q2 2024 at 460,000 shares (US$20.8M). Across 10 filings, P2 Capital Partners, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 320,000 shares valued at US$5.8M. Notable position changes include a 28% trim in Q4 2024 (shares fell 13% over the following quarter), a 87% increase in Q2 2025 (shares fell 3% over the following quarter), a 46% trim in Q1 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 460.00K | $20.79M | New |
| Q3 2024 | 460.00K | $19.80M | Hold |
| Q4 2024 | 330.00K | $14.48M | Reduce |
| Q1 2025 | 330.00K | $12.61M | Hold |
| Q2 2025 | 617.15K | $19.35M | Add |
| Q3 2025 | 595.00K | $18.05M | Reduce |
| Q4 2025 | 595.00K | $15.85M | Hold |
| Q1 2026 | 320.00K | $7.28M | Reduce |
| Q2 2026 | 320.00K | $6.62M | Hold |
| Q3 2026 | 320.00K | $5.85M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENOV and 13F data
ENOV (ENOVIS CORPORATION) is a Health Care company. 17 other funds we track also report a position in ENOV — the largest reported positions include Rubric Capital Management LP (US$80.7M), OAKTREE CAPITAL MANAGEMENT LP (US$37.8M), PRIVATE MANAGEMENT GROUP INC (US$32.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENOV
- Rubric Capital Management LP 3.90M sh · $80.73M · Q2 2026
- OAKTREE CAPITAL MANAGEMENT LP 39.21M sh · $37.79M · Q2 2026
- PRIVATE MANAGEMENT GROUP INC 1.79M sh · $32.75M · Q3 2026
- PARADIGM CAPITAL MANAGEMENT INC/NY 1.66M sh · $30.26M · Q3 2026
- Front Street Capital Management, Inc. 1.45M sh · $26.48M · Q3 2026
More on P2 Capital Partners, LLC
FAQ
How long has P2 Capital Partners, LLC held ENOV?
P2 Capital Partners, LLC has disclosed ENOV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is P2 Capital Partners, LLC's current position in ENOV?
As of Q3 2026, P2 Capital Partners, LLC holds 320.00K shares of ENOV (ENOVIS CORPORATION), valued at $5.85M, representing 1.95% of its reported portfolio and ranking #14.
Has P2 Capital Partners, LLC been buying or selling ENOV?
In the latest 13F filing (Q3 2026), P2 Capital Partners, LLC held unchanged its position in ENOV.
Which other funds hold ENOV?
Other major institutional holders of ENOV include Rubric Capital Management LP, OAKTREE CAPITAL MANAGEMENT LP, PRIVATE MANAGEMENT GROUP INC, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.